Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2023-03-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
关于上海微创电生理医疗科技股份有限公司2023年度日常关联交易预计的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities Co., Ltd. regarding the 2023 expected ordinary related-party transactions of Shanghai MicroPort EP MedTech Co., Ltd. It includes detailed descriptions of related-party transactions, their amounts, approval procedures, independent director opinions, audit committee opinions, and financial data of related parties. The document is a formal verification or audit opinion on expected related-party transactions for the year 2023, which is a type of audit or compliance report rather than a full annual or interim financial report. It does not contain comprehensive financial statements or management discussion and analysis but focuses on the audit and verification of related-party transactions. Therefore, it fits best under the category of Audit Report / Information (AR). The document length (6601 characters) and content confirm it is not a brief announcement or a report publication notice, nor is it a regulatory filing or certification letter. Hence, the classification is AR with high confidence. FY 2023
2023-03-28 Chinese
关于为公司及其董事、监事、高级管理人员购买责任险的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shanghai MicroPort EP MedTech Co., Ltd. regarding the purchase of liability insurance for the company and its directors, supervisors, and senior management. It includes details about the insurance plan, the board's resolution, and the independent directors' opinion. The document is short (1102 characters) and does not contain financial statements or detailed financial data. It is an announcement about a corporate governance and risk management measure rather than a report or detailed filing. It does not fit into categories like Annual Report, Interim Report, or Management Report. It is not a regulatory certification or officer attestation. The content relates to board/management matters but specifically about insurance purchase, which is a governance-related announcement. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-28 Chinese
关于营业收入扣除事项的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a specialized audit opinion report issued by Da Hua Certified Public Accountants regarding the company's 2022 fiscal year revenue deduction matters. It references the audit report number and the fiscal period (2022-01-01 to 2022-12-31). The document includes detailed financial information about revenue deductions and is prepared to comply with Shanghai Stock Exchange listing rules. It is not a full annual report but a standalone audit-related report focusing on a specific financial aspect (revenue deductions). The document length is about 5870 characters, which is sufficient to contain substantive content rather than just an announcement. Therefore, this document fits the category of an Audit Report / Information (AR) rather than an Annual Report (10-K) or a Regulatory Filing (RNS).
2023-03-28 Chinese
内部控制审计报告
Regulatory Filings
2023-03-28 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司首次公开发行网下配售限售股上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed report from Huatai United Securities regarding the unlocking and listing of restricted shares for Shanghai MicroPort EP MedTech Co., Ltd. It discusses the types of restricted shares, the number of shares becoming tradable, the lock-up period, shareholder commitments, and provides a detailed list of shareholders and their shareholdings. The document references regulatory approvals and stock exchange rules, and it is focused on the specific event of restricted shares becoming freely tradable after the lock-up period. This is not a general financial report, earnings release, or management discussion. It is a formal verification and opinion on the unlocking and circulation of restricted shares, which is a capital market event related to share circulation and shareholder information. This type of document fits best under the category of Regulatory Filings (RNS) because it is a regulatory disclosure about share circulation and compliance with lock-up commitments, and it does not fit the other more specific categories such as Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS) since it is about unlocking existing restricted shares rather than issuing new shares or buybacks. The document length is substantial and contains detailed data, so it is not a mere announcement of a report (RPA). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-02-20 Chinese
首次公开发行网下配售限售股上市流通公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the listing and circulation of restricted shares from the company's initial public offering (IPO) offline placement. It details the number of shares becoming freely tradable after the lock-up period, the shareholders involved, and the compliance with regulatory approvals from the China Securities Regulatory Commission. The document does not contain financial statements, earnings data, or management discussion but focuses on the share circulation event and related shareholder information. This fits the category of a Share Issue/Capital Change announcement, as it concerns the change in share circulation status and capital structure due to the release of restricted shares post-IPO lock-up period.
2023-02-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.